Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy

被引:16
|
作者
Liu, R. [1 ]
Liu, C-M [2 ]
Cui, L-L [1 ]
Zhou, L. [3 ]
Li, N. [1 ]
Wei, X-D [1 ]
机构
[1] Tangshan Worker Hosp, Dept Ophthalmol, Tangshan, Peoples R China
[2] Tangshan Worker Hosp, Dept Emergency Med, Tangshan, Peoples R China
[3] Tangshan Worker Hosp Grp Rehabil Hosp, Dept Ophthalmol, Tangshan, Peoples R China
关键词
MiR-126; VEGF; Proliferative diabetic retinopathy; GROWTH; NEOVASCULARIZATION; MICRORNA-126;
D O I
10.26355/eurrev_201908_18518
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To study the expression and significance of micro ribonucleic acid (miR)-126 and vascular endothelial growth factor (VEGF) in the vitreous body and proliferative membrane tissues of affected eyes and plasma in proliferative diabetic retinopathy (PDR). PATIENTS AND METHODS: A total of 50 PDR patients admitted to our hospital from January 2017 to January 2018 were collected, including 17 cases in stage IV, 20 cases in stage V, and 13 cases in stage VI according to the DR staging criteria. Another 30 patients with an idiopathic macular hole were selected as control group. After admission, the examinations were performed, venous blood was drawn, and vitrectomy was performed, during which the vitreous body and proliferative membrane tissues were taken. The plasma VEGF content was detected via enzyme-linked immunosorbent assay (ELISA). The VEGF protein expression level was detected via Western blotting in vitreous body and proliferative membrane tissues. Moreover, the miR-126 expression was detected via quantitative polymerase chain reaction (qPCR). RESULTS: In the vitreous body tissues, proliferative membrane tissues and plasma, the expression level of miR-126 was significantly lower in control group than that in stage IV, V, and VI groups (p<0.05). The miR-126 expression was significantly lower in stage IV group than that in stage V and VI groups (p<0.05), meanwhile, miR-126 expression was significantly lower in stage V group than that in stage VI group (p<0.05). In the vitreous body tissues, proliferative membrane tissues and plasma, the VEGF mRNA and protein expression levels were significantly higher in control group than those in stage IV, V, and VI groups (p<0.05). The VEGF expressions were significantly higher in stage IV group than those in stage V and VI groups (p<0.05). In addition, VEGF expressions were significantly higher in stage V group than those in stage VI group (p<0.05). Furthermore, the VEGF expression level was negatively correlated with the miR-126 expression level. CONCLUSIONS: We found that the abnormally high expression of miR-126 negatively regulates VEGF, which may be one of the important mechanisms of occurrence of PDR. The miR-126 and VEGF content can serve as important predictors for the condition of PDR.
引用
收藏
页码:6387 / 6393
页数:7
相关论文
共 50 条
  • [31] Evaluation of VEGF gene polymorphisms and proliferative diabetic retinopathy in Mexican population
    Gonzalez-Salinas, Roberto
    Garcia-Gutierrez, Maria C.
    Garcia-Aguirre, Gerardo
    Morales-Canton, Virgilio
    Velez-Montoya, Raul
    Soberon-Ventura, Vidal R.
    Gonzalez, Victoria
    Lechuga, Rodrigo
    Garcia-Solis, Pablo
    Garcia-Gutierrez, David G.
    Vinicio Garcia-Solis, Marco
    Saenz de Viteri, Manuel
    Solis-S, Juan C.
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (01) : 135 - 139
  • [32] MiR-126 enhances VEGF expression in induced pluripotent stem cell-derived retinal neural stem cells by targeting spred-1
    Ye, Lin
    Peng, Yun
    Mo, Jinsong
    Yao, Yuanyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (02): : 1023 - 1030
  • [33] Evaluation of the Expression Level and Hormone Receptor Association of miR-126 in Breast Cancer
    Rouigari, Maedeh
    Dehbashi, Moein
    Tabatabaeian, Hossein
    Ghaedi, Kamran
    Mohammadynejad, Parisa
    Azadeh, Mansoureh
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2019, 34 (04) : 451 - 457
  • [34] Intraocular expression of thymosin β4 in proliferative diabetic retinopathy
    Wang, Jia-Yan
    Lu, Qiang
    Tao, Yong
    Jiang, Yan-Rong
    Jonas, Jost B.
    ACTA OPHTHALMOLOGICA, 2011, 89 (05) : E396 - E403
  • [35] miR-126: A novel regulator in colon cancer
    Huang, Weina
    Lin, Jie
    Zhang, Hongxuan
    BIOMEDICAL REPORTS, 2016, 4 (02) : 131 - 134
  • [36] Differential expression of vitreous proteins in proliferative diabetic retinopathy
    Kim, SJ
    Kim, S
    Park, J
    Lee, HK
    Park, KS
    Yu, HG
    Kim, Y
    CURRENT EYE RESEARCH, 2006, 31 (03) : 231 - 240
  • [37] VEGF-Independent Activation of Muller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
    Rezzola, Sara
    Guerra, Jessica
    Chandran, Adwaid Manu Krishna
    Loda, Alessandra
    Cancarini, Anna
    Sacristani, Piergiuseppe
    Semeraro, Francesco
    Presta, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 16
  • [38] MicroRNA-126 (MiR-126): key roles in related diseases
    Liao, Li
    Tang, Yan
    Zhou, Yanping
    Meng, Xianglin
    Li, Bo
    Zhang, Xiaochun
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2024, 80 (02) : 277 - 286
  • [39] MicroRNA-126 (MiR-126): key roles in related diseases
    Li Liao
    Yan Tang
    Yanping Zhou
    Xianglin Meng
    Bo Li
    Xiaochun Zhang
    Journal of Physiology and Biochemistry, 2024, 80 : 277 - 286
  • [40] Serum microRNA-126 expression as a biomarker of diabetic retinopathy
    Surasmiati, Ni Made Ayu
    Suryathi, Ni Made Ari
    Andayani, Ari
    UNIVERSA MEDICINA, 2023, 42 (02) : 121 - 127